What caused the TMD.TO stock surge today?

The TMD.TO stock surge was driven by extreme intraday liquidity in a low-float microcap. Volume reached **117,220**, well above the average of **45,936**, creating sharp price movement without a single confirmed earnings release.

How does Meyka AI rate TMD.TO stock?

Meyka AI rates TMD.TO with a score out of 100: **64.72**, grade **B**, suggestion **HOLD**. The grade factors in benchmark and sector comparisons, growth metrics, financials and analyst inputs.

What is the short-term forecast for TMD.TO stock?

Meyka AI's forecast model projects a 12-month target of **C$1.45** for TMD.TO stock, implying **28.89%** upside from **C$1.125**. Forecasts are model-based projections and not guarantees.

What risks should traders consider with TMD.TO stock?

Key risks for TMD.TO stock include thin liquidity, large intraday volatility, development-stage losses (**EPS -1.73**), and reliance on regulatory and commercialization milestones for the Enos system.

CA Stocks

2149% intraday jump 30 Jan 2026: TMD.TO Titan Medical (TSX) liquidity test

ByHuzaifa Zahoor January 31, 2026January 31, 2026

TMD.TO stock led intraday movers as Titan Medical Inc. (TSX) surged from an open of C$0.05 to a high of C$1.125 on heavy volume on 30 Jan 2026. The move shows retail and liquidity dynamics in a low-float microcap where volume at 117,220 exceeded the 50-day average by a factor of 2.55. We review price action, financials, risks and a model-driven forecast to frame possible near-term outcomes for Canadian investors.